Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Side Effect of Drug × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 255 Carcinoma, Non-Small-Cell Lung 195 Prostatic Neoplasms 165 Neoplasms 149 Lung Neoplasms 106 Multiple Myeloma 96 Melanoma 91 Colorectal Neoplasms 91 Neoplasm Metastasis 72 Leukemia, Myeloid, Acute 71 Ovarian Neoplasms 69 Leukemia, Lymphocytic, Chronic, B-Cell 69 Squamous Cell Carcinoma of Head and Neck 58 Pancreatic Neoplasms 54 Lymphoma 54 Glioblastoma 54 Brain Neoplasms 51 Lymphoma, Non-Hodgkin 49 Carcinoma, Renal Cell 48 Carcinoma, Hepatocellular 48 Urinary Bladder Neoplasms 47 Recurrence 47 Lymphoma, Large B-Cell, Diffuse 41 Head and Neck Neoplasms 40 Glioma 39 Uterine Cervical Neoplasms 38 Triple Negative Breast Neoplasms 38 Stomach Neoplasms 38 Lymphoma, Follicular 36 Hematologic Neoplasms 36

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04701151 2026-03-03

NORTH-REG Dwell-Time Study

Aarhus University Hospital

Phase 4 Active not recruiting

Side Effect of Drug

Data powered by HemOnc (CC BY 4.0) Colophon ⚡